This 812-page report presents an overview of the clinical significance and market needs for major current and emerging tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.
This report also presents strategic assessments of current and emerging suppliers of molecular diagnostic products, including of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 812 pages and 35 tables
